Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc and hyaluronic acid for reduced ejaculate volume in men
KCT0004369Phase 4Terminated
- Sponsor
- Metacen Therapeutics
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zinc, hyaluronic acid in hypospermia, sponsored by Metacen Therapeutics. Started Jan 2020; status: terminated.
02
Drugs
zinchyaluronic acid
03
Conditions
hypospermia
Beyond the preview
Go deeper on KCT0004369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004369.